Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the pot...
| الحاوية / القاعدة: | Methods and Protocols |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
MDPI AG
2020-08-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/2409-9279/3/3/57 |